References
Rocca P, El Jastimi S, Troncy J, et al. Imatinib mesylate induced acute cytolytic hepatitis. Gastroenterol Clin Biol 2004; 28: 918–9
Ayoub WA, Geller SA, Tran T, et al. Imatinib (Gleevec®)-induced Hepatotoxicity. J Clin Gastroenterol 2005; 39: 75–7
James C, Trouette H, Marit G, et al. Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia 2003; 17: 978–9
Kikuchi S, Muroi K, Takahashi S, et al. Severe Hepatitis and complete molecular response caused by imatinib mesylate: possible association of its serum concentration with clinical outcomes. Leukemia & Lymphoma 2004 Nov; 45: 2349–51
Danan G. Drug-induced acute hepatic injury. What is the value of diagnostic scales? Gastroenterol Clin Biol 2003; 27Suppl.: B21–5
Ganne-carrié N, Leusse A, Guettier C, et al. Autoimmune hepatitis induced by fibrates. Gastroenterol Clin Biol 1998 May; 22(5): 525–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nowak, C., Adehossi, A. & Manela, F. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 937 (2006). https://doi.org/10.2165/00002018-200629100-00034
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200629100-00034